HIGHLIGHTS
- who: . and collaborators from the Jackson Laboratory, United States University of Colorado Anschutz have published the Article: Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy, in the Journal: (JOURNAL)
- what: This study shows that HRR is safe and improvement in LVEF is related to the degree of HRR. The aim of this study is to investigate the relationship between heart rate reduction (HRR) and left ventricular function in pediatric patients in chronic heart failure, with DCM, treated with carvedilol. The analysis showed that there was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.